Allogeneic HSCT is frequently complicated by acute GVHD (~50%) and chronic GVHD (30%–70%), with steroid-refractory disease representing a major unmet need despite ruxolitinib availability. CK0802 ...

Multicenter, open-label study will evaluate the safety and preliminary efficacy of CK0802, a first-in-class, off-the-shelf ...

Trial Met Dual Primary Endpoints of KCCQ and Maximal Exercise Performance With Consistent Positive Findings Across Key ...

Evidence suggests that adoption of oncology biosimilars in Medicare value-based payment models has produced substantial cost ...

You can't dismiss "American Luxury" as marketing hype any more.

Over the past three decades, meaningful progress has been made in the research and understanding of cystic fibrosis (CF). 1 ...

Thanks to a healthy dose of swaggering, capital-F Fashion, the trusty menswear standby looks better than ever.

Ascidian Therapeutics, a biotechnology company seeking to treat human diseases by rewriting RNA, announced the completion of the adult dose escalation portion of the STELLAR phase 1/2 clinical trial ...

Trial Met Dual Primary Endpoints of KCCQ and Maximal Exercise Performance With Consistent Positive Findings Across Key ...

If your iPhone or iPad is not running the latest software update, two exploit kits are built to take advantage of that. The ...

Ascidian Completes Dose Escalation Portion Of Phase 1/2 STELLAR Trial Of ACDN-01 For Stargardt Disease And Announces Expanded Clinical Study Plans. STELLAR to begin enrolling pediatric subjects STARPA ...

Cinnamon, Bitter Melon, Resveratrol, Licorice Root, Turmeric, and Coriander in the Blood Sugar Trap Liquid Tincture Formula ...